SCHEMBL7889606

SCHEMBL7889606

Cc1ccc2nc(O)cn2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.41
COMT P21964 1/20 0.41
RBP4 P02753 1/20 0.39
LRRK2 Q5S007 3/20 0.38
AHR P35869 3/20 0.37
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TTK P33981 5/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
JAK2 O60674 1/20 0.34
METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921056 0.81 DYRK1A (0.58) DYRK1ACOMTRBP4LRRK2AHR
SCHEMBL26373829 0.78 DYRK1A (0.42) DYRK1ACOMTRBP4LRRK2AHR
SCHEMBL12673757 0.76 DYRK1A (0.41) DYRK1ACOMTRBP4AHRPIK3CD
SCHEMBL3086869 0.76 KDM4E (0.44) DYRK1ACOMTRBP4LRRK2AHR
SCHEMBL7895997 0.76 DYRK1A (0.41) DYRK1ACOMTRBP4AHRKDM4E
SCHEMBL25104909 0.76 DYRK1A (0.41) DYRK1ACOMTRBP4LRRK2AHR
SCHEMBL6623486 0.76 KDM4E (0.46) DYRK1ALRRK2AHRKDM4EALDH1A1
SCHEMBL13080159 0.76 PDCD1 (0.36) DYRK1ACOMTLRRK2KDM4EKMT2A
SCHEMBL13050491 0.76 GRN (0.34) DYRK1ACOMTLRRK2AHRPIK3CD
SCHEMBL13750723 0.74 RAB9A (0.54) DYRK1AKDM4EMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150322069-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS FMR LLC 2015-11-12 US disclosed
US-8946222-B2 Phenoxymethyl heterocyclic compounds FORUM PHARMACEUTICALS INC. (US) 2015-02-03 US disclosed
US-20130143888-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS ENVIVO PHAMACEUTICALS, INC. (US) 2013-06-06 US disclosed
WO-2010128995-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS ENVIVO PHARMACEUTICALS, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150322069-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS PDE3A, PDE2A, PDE5A DYRK1A 4075/4885COMT 43/4885RBP4 4674/4885
US-20130143888-A1 PHENOXYMETHYL HETEROCYCLIC COMPOUNDS PDE3A, PDE2A, PDE5A DYRK1A 4075/4885COMT 43/4885RBP4 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.